Cart
sales@molnova.com
3-Hydroxycinnamic acid
CAS No. 14755-02-3
3-Hydroxycinnamic acid( meta-Coumaric acid | m-Coumaric acid | m-Coumarate )
Catalog No. M20834 CAS No. 14755-02-3
3-Hydroxycinnamic acid is a natual product isolated from Cinnamomum cassia Presl?.?3-Hydroxycinnamic acid has antioxidant activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 38 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3-Hydroxycinnamic acid
-
NoteResearch use only, not for human use.
-
Brief Description3-Hydroxycinnamic acid is a natual product isolated from Cinnamomum cassia Presl?.?3-Hydroxycinnamic acid has antioxidant activity.
-
Description3-Hydroxycinnamic acid is a natual product isolated from Cinnamomum cassia Presl?.?3-Hydroxycinnamic acid has antioxidant activity.
-
In Vitro——
-
In Vivo——
-
Synonymsmeta-Coumaric acid | m-Coumaric acid | m-Coumarate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number14755-02-3
-
Formula Weight164.16
-
Molecular FormulaC9H8O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:32 mg/mL (194.93 mM)
-
SMILESO=C(O)/C=C/c1cccc(O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chuang JY Tsai YY Chen SCet al. Induction of G0 / G1 arrest and apoptosis by 3-hydroxycinnamic acid in human cervix epithelial carcinoma (HeLa) cells[J]. Vivo 2005 19(4):683-688.
molnova catalog
related products
-
Glycoprotein IIb Fra...
Glycoprotein IIb Fragment (656-667)
-
DORA-22
DORA-22 is a dual orexin receptor antagonist, improves mild stress-induced insomnia with minimal effect on memoryDORA-22, a dual orexin receptor antagonist, improves mild stress-induced insomnia with minimal effect on memory.
-
Beta-Tocotrienol
Beta-Tocotrienol to serve as a new anticancer agent for treating human lung and brain cancers. It inhibits the growth of both A549 (GI50=1.38±0.334μM) and U87MG (GI50=2.53±0.604μM) cells at rather low concentrations.
